Literature DB >> 3782955

[Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs].

N Yoshiya.   

Abstract

A new ovarian cancer cell line has been established from the dispersed cells taken from a heterotransplanted tumor at the 6th passage in nude mice which had been serially transplanted with a primary lesion of undifferentiated carcinoma (FIGO) of the ovary. Selection of cancerous epithelioid cells was completed by the 4th passage by means of the colonial cloning method. The cell line designated TYK-nu was subcultured serially in Eagle's MEM with 10% FCS more than 100 times over 31 months at March, 1986 and was observed to produce a tumor on implantation into nude mice histologically similar to the original tumor. These cells form a monolayer in a pavement-like arrangement with polygonal cells including giant cells and reveal a lack of contact inhibition. PAS positive substance can be seen in the cytoplasm. Desmosome structure, well-developed cell organelles and glycogen granules can be found by electron microscopy. The population doubling time was about 37 hours and the plating efficiency was 13-17%. All cells were seen to be of the human karyotype on chromosomal analysis and the number of chromosome in the majority of cells was hyperdiploidy with a mode of 56 at the 6th and 84th passages. A submetacentric marker chromosome was present. Using in vitro colony assay, TYK-nu was studied for drug sensitivity to cisplatin, adriamycin, vincristine, 5-fluorouracil and etoposide, and found to be sensitive to cisplatin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782955

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  7 in total

1.  Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.

Authors:  Yilin Zhang; Shravan Kumar Sriraman; Hilary A Kenny; Ed Luther; Vladimir Torchilin; Ernst Lengyel
Journal:  Mol Cancer Ther       Date:  2016-07-27       Impact factor: 6.261

2.  Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis.

Authors:  Mohammed Habis; Kristen Wroblewski; Michael Bradaric; Nadia Ismail; S Diane Yamada; Lacey Litchfield; Ernst Lengyel; Iris L Romero
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

3.  Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Authors:  Y Oji; H Ogawa; H Tamaki; Y Oka; A Tsuboi; E H Kim; T Soma; T Tatekawa; M Kawakami; M Asada; T Kishimoto; H Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-02

4.  Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.

Authors:  Y Kikuchi; J Hirata; K Yamamoto; K Ishii; T Kita; K Kudoh; T Tode; I Nagata; K Taniguchi; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1997-02

5.  Level of Concordance of Pre-, Intra-, and Postoperative Staging in Cervical Cancers (TREYA Study).

Authors:  M Toure; A T Bambara; K K Y Kouassi; E N Seka; J M Dia; I Yao; O Kimso; I Adoubi
Journal:  J Oncol       Date:  2017-09-10       Impact factor: 4.375

6.  The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine.

Authors:  Andrea Balduit; Chiara Agostinis; Alessandro Mangogna; Veronica Maggi; Gabriella Zito; Federico Romano; Andrea Romano; Rita Ceccherini; Gabriele Grassi; Serena Bonin; Deborah Bonazza; Fabrizio Zanconati; Giuseppe Ricci; Roberta Bulla
Journal:  Cancers (Basel)       Date:  2020-05-07       Impact factor: 6.639

7.  Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.

Authors:  Eniko Papp; Dorothy Hallberg; Gottfried E Konecny; Daniel C Bruhm; Vilmos Adleff; Michaël Noë; Ioannis Kagiampakis; Doreen Palsgrove; Dylan Conklin; Yasuto Kinose; James R White; Michael F Press; Ronny Drapkin; Hariharan Easwaran; Stephen B Baylin; Dennis Slamon; Victor E Velculescu; Robert B Scharpf
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.